ArticleHealth science reports2025
Potential Risk of Local Transmission of Mpox in Nepal: An Emerging Public Health Concern.
Article in Health science reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: Monkeypox (Mpox) is a zoonotic disease caused by the monkeypox virus, a double-stranded DNA virus of the Methods: We reviewed global and national epidemiological reports and Mpox case data from the government authority of Nepal to identify Mpox clades with Clade II at the National Public Health Laboratory (NPHL). Results: In Nepal, three cases have been confirmed, all linked with recent travel history to the Middle East country (Saudi Arabia). Mpox reported in Nepal belonged to Clade IIa by sequencing. Additionally, the risk of Mpox transmission among Nepalese individuals in the UN peacekeeping forces stationed in Africa, including a few endemic countries, may be elevated due to shared living conditions, as human-to-human transmission can occur through direct contact, fomites, or respiratory secretions. Conclusion: Nepal should strengthen molecular laboratories, enforce national guidelines, enhance border health monitoring, raise public awareness, and ensure timely diagnosis and treatment. Coordinated strategies and preparedness are crucial to prevent potential outbreaks and enhance national readiness against future Mpox threats in Nepal. It is recommended that the Government of Nepal adopt and implement a One Health approach for the early detection, control, and prevention of Mpox to minimize transmission risks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.